Celebrating 25 years Est 1999-2024
*Across 3 years $2158.56 only $755.50
$189.3 million of cash, cash equivalents and marketable securities as of Septemberย 30, 2024 The company is...
$245.0 million of cash, cash equivalents and marketable securities as of June 30, 2024 The company is...
BOSTON, July 31, 2024 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical...
BP plc (NYSE:BP) – BP expects weak margins in its refining business to impact its second-quarter profits...
The NEST-IN1 clinical study did not meet its primary or secondary efficacy endpoints, and the company will...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.